Deslanoside

去乙酰毛花苷

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDeslanoside
Drug Alias Name去乙酰毛花甙丙deslanosidedeslanosidum毛花强心苷丙毛花强心丙 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/potassium-transporting ATPase inhibitors
TargetsSodium/potassium-transporting ATPase
Therapy Area/IndicationsHeart FailureArrhythmias, Cardiac
Global Approved IndicationsHeart FailureArrhythmias, Cardiac
Approved Indications in ChinaHeart FailureArrhythmias, Cardiac
Original Approved Country/TerritoryJapan
Original Approved Date1955/03/01
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesKyowa Criticare Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Criticare Co LtdJiangsu Giber Pharmaceutical Co Ltd
Inactive CompaniesNovartis Pharma Ag
Active IndicationsHeart FailureArrhythmias, Cardiac
Inactive IndicationsN/A

Other Information

ATC CodeC01AA07
Related LinksWikipediaDrugBankKEGG